4//SEC Filing
Saccomano Nicholas A 4
Accession 0001415889-25-010419
CIK 0001637715other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:32 PM ET
Size
7.8 KB
Accession
0001415889-25-010419
Insider Transaction Report
Form 4
Saccomano Nicholas A
DirectorPresident and CEO
Transactions
- Sale
Class A Common Stock
2025-04-04$3.33/sh−358$1,191→ 4,198 total - Sale
Class A Common Stock
2025-04-07$2.67/sh−516$1,378→ 3,682 total
Footnotes (4)
- [F1]These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $3.10 to $3.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F4]This transaction was executed in multiple trades at prices ranging from $2.57 to $3.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
OnKure Therapeutics, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001609284
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:32 PM ET
- Size
- 7.8 KB